TCL Archive In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure July 5, 1991
TCL Archive GOP Sweep Takes Out Two Old Friends, But Reagan Spoken say He Supports Cancer Program, NIH November 14, 1980
TCL Archive In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra February 27, 1976
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
